Developer of a genetic medicine technology designed to enable targeted delivery beyond the liver for broader therapeutic impact. The company offers a scalable system for extrahepatic delivery at indus...

Healthcare
Boston, MA, United States
Founded 2022
12 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$31M
Last Round
N/A

Get the full picture

Create a free account to unlock Liberate Bio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required